scholarly journals Clinical characteristics and determinants of glycaemic control among type 2 diabetes mellitus (T2DM) patients in Fiji

2020 ◽  
Author(s):  
Pablo Romakin ◽  
Donald Wilson ◽  
Sabiha Khan ◽  
Masoud Mohaammadnezhad

Abstract Background Diabetes is a global health problem reaching pandemic proportions. In Fiji, diabetes has a prevalence rate of 15.6% in 2011which is estimated to rise to 19.3% in 2020. The aim of this study was to determine the proportion of poor glycaemic control level and its determinants among type 2 diabetes mellitus (T2DM) patients. Methods This retrospective study was conducted in three selected health centres in Suva, Fiji with the following inclusion criteria: adult T2DM ≥ 18 years old registered during 2011 to 2016; on treatment for > 1year; had > 4 clinic visits and; had a recent HbA1c result in 2017. Logistic regression analysis was performed and p < 0.05 considered as significant. Results There were 200 female (59.2%) and 138 male (40.8%) T2DM patients in this study with a mean age of 56.5 years (SD = ± 9.9). Most of T2DM patients have poorly controlled random blood sugar (RBS), 67.1% and fasting blood sugar (FBS), 63.0%. Two-thirds (65.4%) had associated medical conditions. The proportion of poor glycaemic control (HbA1c < 7%) was 77.2%. Mean HbA1c was 8.6% (± 2.04). RBS, FBS, cholesterol, estimated glomerular filtration rate (eGFR) and diastolic blood pressure (DBP) were significant (p < 0.05) determinants of poor glycaemic control. Conclusions Health care workers dealing with T2DM patients should consider the clinical determinants of poor glycaemic control for a more effective diabetes management.

2021 ◽  
Author(s):  
Pablo Romakin ◽  
Donald Wilson ◽  
Sabiha Khan ◽  
Masoud Mohaammadnezhad

Abstract Background: Glycemic control is the centre in diabetes management. In patients with type 2 diabetes mellitus (T2DM), glycemic control is associated with clinical determinants. The aim of this study was to determine the proportion of poor glycemic control level and its clinical determinants among T2DM patients.Methods: This retrospective cross-sectional study was conducted on the medical records of T2DM patients attending diabetes clinics at the three selected health centres in Suva, Fiji. Patients who met the following criteria were included in the study: adult T2DM >18 years old registered during 2011 to 2016; on treatment for >1year; had >4 clinic visits and; had a recent HbA1c result in 2017. Logistic regression analysis was performed. A p value of <0.05 was considered as significant.Results: There were 200 female (59.2%) and 138 male (40.8%) T2DM patients included in this study with a mean age of 56.5 years (SD = + 9.9). Majority have poorly controlled random blood sugar (RBS), 67.1% and fasting blood sugar (FBS), 63.0%. Two-thirds (65.4%) had co-morbidities. The proportion of poor glycaemic control (HbA1c <7%) was 77.2% with mean HbA1c of 8.6% (+ 2.04). RBS, FBS, cholesterol, estimated glomerular filtration rate (eGFR) and diastolic blood pressure (DBP) were significant (p<0.05) determinants of poor glycaemic control.Conclusions: This study identified clinical determinants of T2DM patients that are highly associated with glycemic control. Health care workers managing T2DM patients should address these clinical determinants in order to achieve glycemic control.


2019 ◽  
Vol 12 (12) ◽  
pp. e232553 ◽  
Author(s):  
Tomomi Ueda ◽  
Yuya Tsurutani ◽  
Sho Katsuragawa ◽  
Jun Saito

We report a rare case of type 2 diabetes mellitus (T2DM) complicated with idiopathic hypoparathyroidism. A 36-year-old Japanese man was admitted to our hospital owing to poor glycaemic control and hypocalcaemia. The patient had myalgia resulting from hypocalcaemia, which prevented adequate exercise. He considered the onset of myalgia to be an adverse event of oral hypoglycaemic agents and reduced compliance to medication; however, his serum calcium level was never measured. Treatment for hypocalcaemia immediately improved the myalgia, facilitating regular exercise therapy and ensuring compliance with prescribed medications, as the now-resolved myalgia was no longer perceived to be an adverse effect of glucose-lowering agents; this improved glycaemic control. Although hypoparathyroidism is a rare disease, it is necessary to assess serum calcium levels in patients with T2DM, particularly in cases presenting with unidentified complaints such as myalgia.


2021 ◽  
pp. 106-108
Author(s):  
Charchit Mehta ◽  
Vidyasagar C R ◽  
Raveesha A

Objectives- To explore the association of Triglyceride Glucose index with HbA c and To evaluate their 1 potential role as predictors of glycemic control in patients with type 2 diabetes mellitus. Design: observational study Setting: Conducted in the Department of General Medicine at Sri Devaraj Urs medical college, Kolar, Karnataka. Subjects: 98 diabetic subjects were studied and were evaluated for predicting glycemic control using triglyceride glucose index. Results: Among subjects with good glycaemic control (HbA1c <7%) mean Triglyceride was 136 + 21.78 mg/dl and Among subjects with poor glycaemic control (HbA1c >7%) mean Triglyceride was 190.35 + 62.94 mg/dl. there was a statistically signicant difference found between Triglyceride and HbA1c. Among subjects with good glycaemic control (HbA1c <7%) mean Triglyceride glucose index was 9275.06 + 2154.22 mg/dl and Among subjects with poor glycaemic control (HbA1c >7%) mean Triglyceride glucose index was 24223.63+ 15794.73mg/dl. there was a statistically signicant difference found between Triglyceride glucose index and HbA1c Conclusion: We can use Triglyceride glucose index in predicting glycaemic control in type 2 DM which is inexpensive and cost effective.


2012 ◽  
Vol 97 (3) ◽  
pp. 377-384 ◽  
Author(s):  
Elke Raum ◽  
Heike U. Krämer ◽  
Gernot Rüter ◽  
Dietrich Rothenbacher ◽  
Thomas Rosemann ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document